Development of an Innovative Modular System for Continuous Chemical Processing

开发连续化学处理的创新模块化系统

• 批准号: EP/K504117/1
• 负责人: Alastair Florence
• 金额: $ 10.12万
• 依托单位: University of Strathclyde
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2013
• 资助国家: 英国
• 起止时间: 2013 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FK504117%2F1
• 关键词: Development; Innovative; Modular; System; Continuous

The project, lead by Syrris, in collaboration with GSK, AMRI UK and the EPSRC Centre for Innovative Manufacturing inContinuous Manufacturing and Crystallisation will develop an innovative modular system for continuous chemicalprocessing. It will develop modules that can be used by any chemical industry to perform unit operations such as liquidliquid,liquid-solid and liquid-solid-gas phase reactions, crystallisations and aqueous work-up in a continuous process, withanalysis. The modules will be scalable, easy to use, automatable and able to be quickly reconfigured into hundreds ofconceivable single or multi step process systems. Within the project lifetime, this will enable GSK and AMRI to operatemore efficient, high quality and sustainable processes with easier scale-up. After the project, commercialisation of thesemodules will enable the wider chemical process industry to benefit from the same advantages and generate significantexports for the UK.

该项目由 Syrris 牵头，与 GSK、AMRI UK 和 EPSRC 连续制造和结晶创新制造中心合作，将开发用于连续化学处理的创新模块化系统。它将开发任何化学工业可用于执行单元操作的模块，例如连续过程中的液-液、液-固和液-固-气相反应、结晶和水处理，并进行分析。这些模块将具有可扩展性、易于使用、可自动化，并且能够快速重新配置为数百个可想象的单步或多步处理系统。在项目生命周期内，这将使 GSK 和 AMRI 能够运行更高效、高质量和可持续的流程，并且更容易扩大规模。该项目完成后，这些模块的商业化将使更广泛的化学加工行业受益于同样的优势，并为英国带来大量出口。